-
ACLA Comments to Sen. Cassidy’s White Paper on AI
-
ACLA Submits Comments on CMS Medicare Physician Fee Schedule Proposed Rule
-
ACLA Response to Draft Local Coverage Determinations, Genetic Testing for Oncology
-
Appendix to ACLA Response to Draft Local Coverage Determinations, Genetic Testing for Oncology
-
Letter from Leading Cancer-Related Provider Groups and Patient Advocates on Genetic Testing for Oncology
-
ACLA Submits Comments on CMS Transitional Coverage For Emerging Technologies Notice
-
ACLA Submits Comments on CMS Pre-Exposure Prophylaxis (PrEP) Proposed NCD
-
ACLA Submits Comments on the CDC’s NCVHS ICD-11 RFI
-
ACLA Submits Comments on Palmetto Special Stains/IHC Proposed LCD
-
Letter to ONDCP on NCCI Edits for Drug Testing